mobile header

Inflammatory Breast Cancer vs. Mastitis: How to Differentiate Between the Two

Inflammatory breast cancer (IBC) and mastitis can present similar symptoms, making it challenging for many to distinguish between them. Inflammatory breast cancer (IBC) and mastitis are both conditions that can cause breast swelling and redness, but they have some key differences. However, understanding the differences is crucial, as one is a life-threatening condition while the other is often benign. For women and healthcare professionals alike, knowing the signs of both conditions is essential for early detection and effective treatment

blog

What is Inflammatory Breast Cancer?

Inflammatory breast cancer is a rare and aggressive form of breast cancer. Unlike other breast cancers, IBC often does not present as a lump. Instead, it invades lymphatic vessels in the skin of the breast, leading to symptoms that resemble an infection.

The rapid progression of IBC makes early detection critical. Often, a diagnosis occurs at an advanced stage because its symptoms can be mistaken for benign conditions. The American Oncology Institute emphasizes the importance of recognizing these symptoms to ensure timely medical intervention.

Patients at the American Oncology Institute often report skin changes, such as redness, swelling, and a pitted appearance reminiscent of an orange peel. These changes can appear suddenly and worsen quickly, highlighting the urgency of consulting a specialist if such symptoms occur.

Understanding Mastitis

Mastitis is a common condition affecting breastfeeding women, arising from a blocked milk duct or bacterial infection. It leads to painful, swollen, and red breasts, similar to IBC, but the cause and treatment differ significantly.

Breastfeeding women are the most likely to develop mastitis, although it can also occur in non-lactating women. The condition can be very uncomfortable, causing flu-like symptoms. Fortunately, mastitis is treatable with antibiotics and home remedies, such as warm compresses and increased breastfeeding or pumping frequency.

At the American Oncology Institute, consultants stress that while mastitis can be distressing, it is typically less severe than IBC and responds well to medical treatment when caught early.

Examining the Symptoms

Both IBC and mastitis present with breast redness and swelling, but there are distinctions worth noting. Mastitis usually affects a specific area of the breast, whereas IBC can cause widespread inflammation.

In the case of IBC, you may notice a rapid increase in breast size, persistent itching, and tenderness. The skin might thicken and pit, resembling the texture of an orange peel. Patients often experience these symptoms without accompanying flu-like symptoms, unlike mastitis.

For mastitis, common indicators include localized pain, fever, and generally feeling unwell. These flu-like symptoms are key in differentiating it from IBC. Consulting with a doctor from the American Oncology Institute can help clarify any uncertainty.

Causes Behind the Conditions

The underlying causes of IBC and mastitis differ significantly. IBC results from cancerous cells blocking lymph vessels in breast skin, leading to inflammation and characteristic symptoms. Most people experience swelling and reddening of the breast instead of a bump. Inflammatory symptoms are caused by this form of cancer because it inhibits the lymph veins.

Conversely, mastitis typically stems from milk trapped in the breast tissue, leading to bacterial growth and infection. It can also arise from bacteria entering through a cracked nipple, common among breastfeeding mothers.

Understanding these causes underscores the importance of accurate diagnosis, as the treatments for each condition vary substantially.

Diagnosis Methods

Accurate diagnosis is vital in distinguishing between IBC and mastitis. For IBC, doctors at the American Oncology Institute recommend a combination of imaging tests, such as mammograms and ultrasounds, alongside a biopsy to confirm the presence of cancerous cells.

In contrast, mastitis is generally diagnosed through a physical exam and medical history. Doctors may prescribe antibiotics if bacterial infection is suspected. If symptoms persist despite treatment, further investigation might be necessary to rule out other conditions.

Early and accurate diagnosis is crucial, as it influences treatment decisions and patient outcomes.

Treatment Options

Treatment for IBC and mastitis diverges significantly due to their different natures. For IBC, a multidisciplinary approach involving surgery, chemotherapy, and radiation therapy is often necessary. Systemic chemotherapy is typically used to help decrease the tumour in inflammatory breast cancer before surgery is performed to remove the tumour and radiation therapy is administered. This therapy strategy is known as a multimodal strategy.

Additional therapies for IBC consist of:

  • Targeted treatment

  • IBCs that generate significant amounts of the HER2 protein can be treated with medications such as trastuzumab (Herceptin).
  • Hormonal treatment

  • able to treat certain types of IBC. For instance, aromatase inhibitors such as anastrozole may be prescribed for five years to postmenopausal women with hormone receptor-positive IBC.
  • Palliative care

  • Management that assist patients and their families live better lives by reducing pain and other symptoms.

The American Oncology Institute offers all these comprehensive treatment plans tailored to each patient’s needs.

In comparison, mastitis can usually be managed with antibiotics, rest, and self-care measures. Increasing breastfeeding frequency or pumping can help relieve symptoms by promoting milk flow.

Understanding these treatment differences can help patients seek the appropriate care promptly.

Preventative Measures

While it’s challenging to prevent IBC due to its aggressive nature, early detection remains key. Regular breast self-exams and awareness of changes in breast appearance or feel can prompt timely medical evaluation.

For mastitis, measures such as proper breastfeeding techniques, frequent feeding, and addressing any nipple issues can reduce the risk. The American Oncology Institute encourages lactating women to consult with healthcare providers to learn effective breastfeeding practices.

Educating oneself about these preventative measures can empower women to take proactive steps in managing their breast health.

The Role of the American Oncology Institute

The American Oncology Institute plays a pivotal role in providing expert care and guidance for those affected by IBC. Their team of specialized doctors is equipped to handle the complexities of this aggressive cancer, offering cutting-edge treatments and compassionate support.

Patients seeking diagnosis or treatment can benefit from the Institute’s range of services, including advanced imaging, targeted therapies, and personalized care plans designed to address individual needs and improve outcomes.

Differentiating Between IBC and Mastitis

Many times, inflammatory breast cancer is confused with cellulitis, a bacterial illness, or mastitis, an infection that can happen when nursing. Fever is frequently caused by cellulitis and mastitis, but it is not a sign of inflammatory breast cancer. Recognizing the differences between IBC and mastitis is essential for ensuring timely and appropriate treatment. While their symptoms may overlap, the underlying causes and necessary interventions vary greatly. If you notice persistent changes in your breast that don’t align with mastitis symptoms, consult with an expert at the American Oncology Institute. Early detection and intervention are crucial in managing IBC effectively.

Conclusion

Understanding the distinction between inflammatory breast cancer and mastitis is key to addressing each condition appropriately. IBC is thought to spread quickly, therefore it's critical to begin therapy as soon as possible after being diagnosed. While mastitis is often easy to treat, IBC requires urgent medical attention.